Compounded Semaglutide
We understand weight loss isn’t about willpower— it’s about consistency. Lose up to 14.9% of your body weight with this simple, weekly GLP-1— tailored just to you.
$99 first month | $197/mo after
$196 first month | $296/mo after
We understand weight loss isn’t about willpower— it’s about consistency. Lose up to 14.9% of your body weight with this simple, weekly GLP-1— tailored just to you.
What is compounded semaglutide?
Compounded semaglutide (compounded GLP-1) can be a medication prescribed for weight loss. It contains the same active ingredient as the groundbreaking medications Wegovy® and Ozempic®.
Compounded GLP-I medications work by mimicking hormones that regulate appetite and digestion — potentially leading to weight loss when combined with diet and exercise.
Compounded semaglutide is customized uniquely for each individual by a state licensed compounding pharmacy. Once prescribed by one of Goals’s network of licensed healthcare professionals, compounded semaglutide is self-injected just once a week.
Is compounded semaglutide safe?
At Eden, we source compounded semaglutide from accredited 503a compounding pharmacies that have a reputation for safety. However, like any medication, there may be side effects. These are usually mild and go away within a couple of weeks. See more safety information here.
Why choose Goal MD for compounded semaglutide?
Eden’s personalized weight loss solutions are focused on you. Access to injectable (compounded) semaglutide is sourced from audited and licensed US-based compounding pharmacies. It is always available in a customized dosage catered to your specific needs. We also offer a free initial consultation with a network healthcare provider, consistent pricing regardless of dose, and 24/7 access to online support.
Only available if prescribed after an online consultation with a healthcare provider. Benefits outlined are based on third-party studies. Plans are offered as a subscription service which can be canceled at any time. Actual product packaging may appear differently than shown. Physicians may prescribe compounded medications as needed to meet patient requirements or address drug shortages. The FDA does not review or approve any compounded medications for safety or effectiveness. Compounded semaglutide has not been approved by the FDA for weight loss, but studies indicate potential benefits. Results may vary.
*After 68 weeks, participants administering once-weekly semaglutide treatment experienced an average of 15% reduction in body weight. The mean change in body weight from baseline to week 68 was −14.9% in the semaglutide group as compared with −2.4% with placebo. (Source)
Safely and affordably hit weight management goals with the same weight loss ingredient as brand-name GLP-1 medication
Reduces the need for restrictive diets by naturally regulating appetite, offering a sustainable way to manage weight long-term.
*When combined with diet and exercise.
Associated with improved heart health, lower cholesterol levels, and enhanced overall metabolic health.
*Source: PubMed Central and National Library of Medicine
Has been found to improve blood sugar levels, which may reduce the risk of type 2 diabetes.
*Source: National Library of Medicine
Experience an average
weight loss of
while on a GLP-1 medication like Semaglutide*
Health gains beyond numbers
Semaglutide has been shown to improve blood sugar control and diabetes risk. GLP-1 medications have also been found to help protect the heart, lowering the risk of cardiovascular complications, like stroke and heart attack, by up to 14 percent in those with obesity and diabetes.*
*A study found GLP-1 RAs to be associated with a significant 12-14% reduction in major adverse cardiovascular events (Source)
Goal members report
an average of
lost in the first month**
*After 68 weeks, participants administering once-weekly semaglutide treatment (combined with diet and exercise) experienced an average of 14.9% reduction in body weight, compared with 2.4% for the placebo. (Source)
**Weight loss based on self reported data from 160 Goal members while on GLP-1 injections, while combined with diet and exercise.
Proven results,
clinically tested
Semaglutide has been shown to improve blood sugar control and diabetes risk. GLP-1 medications have also been found to help protect the heart, lowering the risk of cardiovascular complications, like stroke and heart attack, by up to 14 percent in those with obesity and diabetes.*
Our pharmacies perform third party testing through FDA and DEA registered labs to run quality control checks for every compounded lot prescribed for Goal patients. They test four key characteristics that are associated with quality and safety.
Member success stories
Supercharge your weight loss goals
* Cardiovascular Disease Risk Factors: Improvement in triglycerides and systolic blood pressure begins with 2-5% weight loss. For diastolic blood pressure and HDL cholesterol, improvement begins at 5-10% weight loss. (Source)
Emotional Health: Pursuing dietary interventions for obese patients with comorbid depression could have the additional benefit of relieving some of their depressive symptoms as well as improving their metabolic profile and cardiovascular risk. (Source)
Weight Loss: After 68 weeks, participants administering once-weekly semaglutide treatment experienced an average of 14.9% reduction in body weight, compared with 2.4% for the placebo. (Source)
FOLLOW US
COMPANY
CUSTOMER CARE
LEGAL
Copyright 2025. GOAL MD. All Rights Reserved.